In light of these findings, it is proposed that DNA-PK be activated for the initial DNA repair and significantly increase the sensitivity to the specific inhibitor of DNA-PK in the CtBP1/2 knockdown serous ovarian cancer cells. The gene discussed is PRKDC; the disease is ovarian serous adenocarcinoma.